Skip to content

Effect on Early Ocular Blood Flow after Cataract Surgery with Different Fluidics System in High Myopia Cases

Effect on Early Ocular Blood Flow after Cataract Surgery with Different Fluidics System in High Myopia Cases

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042085
Enrollment
Unknown
Registered
2021-01-13
Start date
2021-01-08
Completion date
Unknown
Last updated
2021-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cataract

Interventions

Group 1:CENTURION IOP =40mmHg
Group 2:CENTURION IOP =70mmHg
Group 3:Infinity 95cmH2O

Sponsors

Shenyang Aier Excellence Eye Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Over 40 years old, no gender limit; 2. Patients with simple and complex cataracts need to undergo phacoemulsification; 3. Able to understand the purpose of the trial, voluntarily participate in the informed consent form signed by the patient or his legal guardian.

Exclusion criteria

Exclusion criteria: 1. Preoperative patients with other eye diseases and contraindications to implantation of intraocular lenses, such as small eyeballs, heavier corneal lesions, lens dislocation, uveitis, choroidal hemorrhage, and other serious eye diseases; 2. Patients with severe or unstable heart, liver, kidney, lung, endocrine (including thyroid insufficiency), blood, mental and nerve dysfunction and other diseases that may affect the results of the study and cannot cooperate with follow-up; 3. Hard nuclear cataract above grade IV; 4. Glaucoma patients with severe ischemic optic neuropathy and optic atrophy; 5. The surgical eye has suffered trauma or surgery, or requires intraoperative combined surgery to affect the results of this study; 6. The patient participated in other clinical trials; 7. Other situations where the researcher judges that the patient is not suitable for inclusion.

Design outcomes

Primary

MeasureTime frame
OA-PSV;OA-EDV;OA-RI;CRA-PSV;CRA-EDV;CRA-RI;PCA-PSV;PCA-EDV;PCA-RI;SFCT;Macular area Retinal blood vessel density;

Secondary

MeasureTime frame
IOP;UCVA;BCVA;RNFL;

Countries

China

Contacts

Public ContactZhang Jinsong

Shenyang Aier Excellence Eye Hospital

cmu4h-zjs@126.com+86 13066667486

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026